Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.
J Headache Pain
; 20(1): 90, 2019 Aug 29.
Article
in En
| MEDLINE
| ID: mdl-31464581
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidines
/
Pyridines
/
Benzamides
/
Cardiovascular Diseases
/
Serotonin Receptor Agonists
/
Migraine Disorders
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Headache Pain
Journal subject:
MEDICINA INTERNA
/
NEUROLOGIA
/
PSICOFISIOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom